Literature DB >> 11454890

Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever.

M E Santolaya1, A M Alvarez, A Becker, J Cofré, N Enríquez, M O'Ryan, E Payá, J Pilorget, C Salgado, J Tordecilla, M Varas, M Villarroel, T Viviani, M Zubieta.   

Abstract

PURPOSE: To identify clinical and laboratory parameters present at the time of a first evaluation that could help predict which children with cancer, fever, and neutropenia were at high risk or low risk for an invasive bacterial infection. PATIENTS AND METHODS: Over a 17-month period, all children with cancer, fever, and neutropenia admitted to five hospitals in Santiago, Chile, were enrolled onto a prospective protocol. Associations between admission parameters and risk for invasive bacterial infection were assessed by univariate and logistic regression analyses.
RESULTS: A total of 447 febrile neutropenic episodes occurred in 257 children. Five parameters were statistically independent risk factors for an invasive bacterial infection. Ranked by order of significance, they were as follows: C-reactive protein levels of 90 mg/L or higher (relative risk [RR], 4.2; 95% confidence interval [CI], 3.6 to 4.8); presence of hypotension (RR, 2.7; 95% CI, 2.3 to 3.2); relapse of leukemia as cancer type (RR, 1.8, 95% CI, 1.7 to 2.3); platelet count less than or equal to 50,000/mm(3) (RR, 1.7; 95% CI, 1.4 to 2.2); and recent (< or = 7 days) chemotherapy (RR, 1.3; 95% CI, 1.1 to 1.6). Other previously postulated risk factors (magnitude of fever, monocyte count) were not independent risk factors in this study population.
CONCLUSION: In a large population of children, common clinical and laboratory admission parameters were identified that can help predict the risk for an invasive bacterial infection. These results encourage the possibility of a more selective management strategy for these children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454890     DOI: 10.1200/JCO.2001.19.14.3415

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  43 in total

1.  Treating low-risk febrile neutropenia: Jenny's story.

Authors:  R Phillips; R Skinner; J C Chisholm
Journal:  Arch Dis Child       Date:  2007-01       Impact factor: 3.791

2.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

3.  Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.

Authors:  Dominique D Benoit; Pieter O Depuydt; Renaat A Peleman; Fritz C Offner; Koenraad H Vandewoude; Dirk P Vogelaers; Stijn I Blot; Lucien A Noens; Francis A Colardyn; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

Review 4.  Smart electrospun nanofibers for controlled drug release: recent advances and new perspectives.

Authors:  Lin Weng; Jingwei Xie
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 5.  Outpatient management of febrile neutropenia in children with cancer.

Authors:  Mark Holdsworth; Jeff Hanrahan; Bernadette Albanese; Jami Frost
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

6.  Evaluation of predictors of adverse outcome in febrile neutropenic episodes in pediatric oncology patients.

Authors:  Meenakshi Bothra; Rachna Seth; Arti Kapil; S N Dwivedi; Shinjini Bhatnagar; Immaculata Xess
Journal:  Indian J Pediatr       Date:  2012-12-21       Impact factor: 1.967

7.  Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.

Authors:  Roland A Ammann; Christoph Aebi; Andreas Hirt; Annette Ridolfi Lüthy
Journal:  Support Care Cancer       Date:  2004-07-08       Impact factor: 3.603

8.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative.

Authors:  Jeremy Rosenblum; Juan Lin; Mimi Kim; Adam S Levy
Journal:  Pediatr Blood Cancer       Date:  2012-10-09       Impact factor: 3.167

9.  Etiology and clinical course of febrile neutropenia in children with cancer.

Authors:  Hana Hakim; Patricia M Flynn; Katherine M Knapp; Deo Kumar Srivastava; Aditya H Gaur
Journal:  J Pediatr Hematol Oncol       Date:  2009-09       Impact factor: 1.289

10.  A pilot study of the efficacy and safety of empiric daptomycin therapy in oncology patients with fever and severe neutropenia.

Authors:  Joseph S Bubalo; Ravina Kullar; Richard T Maziarz
Journal:  Ther Adv Infect Dis       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.